XML 141 R39.htm IDEA: XBRL DOCUMENT v3.21.2
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 6 Months Ended
Jun. 21, 2021
May 28, 2021
May 26, 2021
Feb. 04, 2021
Jan. 19, 2021
Oct. 16, 2020
Aug. 18, 2020
Jun. 04, 2020
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2020
Mar. 31, 2020
Jun. 30, 2021
Dec. 31, 2020
Aug. 21, 2020
Class of Stock [Line Items]                              
Preferred stock shares desginated                 47,000       47,000 47,000  
Preferred stock liquidation per share                 $ 1,000       $ 1,000 $ 1,000  
Preferred stock liquidation value                 $ 43,000,000       $ 43,000,000 $ 43,000,000  
Common stock, par value                           $ 0.02  
Share-based Payment Arrangement, Expense                 $ 30,000   $ 54,000        
Earnings Per Share, Basic and Diluted                 $ 0.01   $ 0.04        
Stock Issued During Period, Value, New Issues                 $ 45,748,000 $ 61,068,000 $ 6,185,000 $ 4,054,000      
Share based compensation                 $ 45,000       $ 90,000    
Investor [Member]                              
Class of Stock [Line Items]                              
Issuance of common stock, net, shares               21,000              
Stock Issued During Period, Value, New Issues               $ 210,000              
February Two Thousand Twenty One Underwriting Agreement [Member] | Maximum [Member]                              
Class of Stock [Line Items]                              
Options to purchase additional shares       1,847,901                      
May Two Thousand Twenty One Underwriting Agreement [Member] | Maximum [Member]                              
Class of Stock [Line Items]                              
Options to purchase additional shares     4,350,000                        
Common Stock [Member]                              
Class of Stock [Line Items]                              
Issuance of common stock, net, shares                 33,350,000 21,834,000 896,000 863,000      
Stock Issued During Period, Value, New Issues                 $ 668,000 $ 436,000 $ 17,000 $ 18,000      
Series A Preferred Stock [Member]                              
Class of Stock [Line Items]                              
Preferred stock liquidation value             $ 1,000                
Impact BioMedical, Inc. [Member]                              
Class of Stock [Line Items]                              
Number of authorized shares of preferred stock             47,000                
Preferred stock par value             $ 0.02                
Impact BioMedical, Inc. [Member] | Maximum [Member]                              
Class of Stock [Line Items]                              
Equity ownership percentage                             100.00%
Impact BioMedical, Inc. [Member] | Series A Preferred Stock [Member]                              
Class of Stock [Line Items]                              
Preferred stock shares desginated             47,000                
Preferred stock liquidation per share             $ 1,000                
Preferred stock liquidation value             $ 46,868,000                
Conversion price             $ 6.48                
Conversion shares             154.32                
Equity ownership percentage             19.99%                
Impact BioMedical, Inc. [Member] | Series A Preferred Stock [Member] | Common Stock [Member]                              
Class of Stock [Line Items]                              
Conversion shares             7,232,670                
Global BioMedical Pte Ltd [Member]                              
Class of Stock [Line Items]                              
Conversion shares 7,259 35,316       4,293                  
Global BioMedical Pte Ltd [Member] | Series A Convertible Preferred Stock [Member]                              
Class of Stock [Line Items]                              
Conversion shares 1,120,170 5,450,000       662,500                  
Aegis Capital Corp [Member] | Jan. 2021 Underwriting Agreement [Member]                              
Class of Stock [Line Items]                              
Issuance of common stock, net, shares         6,666,666                    
Common stock, par value         $ 0.02                    
Shares Issued, Price Per Share         $ 3.60                    
Proceeds from net offering         $ 24,900,000                    
Aegis Capital Corp [Member] | Jan. 2021 Underwriting Agreement [Member] | Maximum [Member]                              
Class of Stock [Line Items]                              
Options to purchase additional shares         1,000,000                    
Aegis Capital Corp [Member] | February Two Thousand Twenty One Underwriting Agreement [Member]                              
Class of Stock [Line Items]                              
Issuance of common stock, net, shares       12,319,346                      
Common stock, par value       $ 0.02                      
Shares Issued, Price Per Share       $ 2.80                      
Proceeds from net offering       $ 36,140,000                      
Aegis Capital Corp [Member] | May Two Thousand Twenty One Underwriting Agreement [Member]                              
Class of Stock [Line Items]                              
Issuance of common stock, net, shares     29,000,000                        
Common stock, par value     $ 0.02                        
Shares Issued, Price Per Share     $ 1.50                        
Proceeds from net offering     $ 45,750,000